US added a second COVID-19 vaccine to its arsenal
Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. And the National Institutes of Health.
The move marks the world s first authorization for Moderna s shots.
WASHINGTON: Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
BW Businessworld
Moderna Gets Emergency Use Authorisation For Its COVID-19 Vaccine In US
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
Photo Credit :
Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
Moderna gets emergency use authorisation for its COVID-19 vaccine in US
Representative Image
Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA). Congratulations, the Moderna vaccine is now available! President Donald Trump tweeted soon after.
The FDA based its recommendation on the totality of scientific evidence shared by Moderna, including a data analysis from the pivotal phase three clinical study announced on November 30. The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1 per cent.
Coronavirus pandemic: Moderna gets emergency use authorisation for its COVID-19 vaccine in US financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
US Gives Nod To Moderna For Emergency Use Of Its Covid Vaccine
FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
PTI 19 December 2020 AP PTI 2020-12-19T08:32:09+05:30 US Gives Nod To Moderna For Emergency Use Of Its Covid Vaccine outlookindia.com 2020-12-19T09:14:26+05:30
Also read
Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).